GB1432784A - Orally administrable pharmaceutical compositions - Google Patents

Orally administrable pharmaceutical compositions

Info

Publication number
GB1432784A
GB1432784A GB5273473A GB5273473A GB1432784A GB 1432784 A GB1432784 A GB 1432784A GB 5273473 A GB5273473 A GB 5273473A GB 5273473 A GB5273473 A GB 5273473A GB 1432784 A GB1432784 A GB 1432784A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
orally administrable
nov
administrable pharmaceutical
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5273473A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of GB1432784A publication Critical patent/GB1432784A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1432784 Orally administrable medicines SUMITOMO CHEMICAL CO LTD 13 Nov 1973 [18 Nov 1972] 52734/73 Heading A5B Pharmaceutical compositions for oral administration having enhanced resorbability of the drug comprise a drug dissolved or suspended in a liquid mono-glyceride of a C6-12 fatty acid or a mixture of such glycerides. Various drugs are mentioned including chloramphenicol, grisiofulrin, phenobarbitol, aspirin, sulpha drugs, indomethacin, diazepam, pentazocine and 1-cyclopropylmethyl-4-phenyl-6- chloro-2(1H) quinazolinone.
GB5273473A 1972-11-18 1973-11-13 Orally administrable pharmaceutical compositions Expired GB1432784A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11602172A JPS4971127A (en) 1972-11-18 1972-11-18

Publications (1)

Publication Number Publication Date
GB1432784A true GB1432784A (en) 1976-04-22

Family

ID=14676810

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5273473A Expired GB1432784A (en) 1972-11-18 1973-11-13 Orally administrable pharmaceutical compositions

Country Status (6)

Country Link
JP (1) JPS4971127A (en)
BE (1) BE807312A (en)
CA (1) CA1036072A (en)
DE (1) DE2357389A1 (en)
FR (1) FR2206943B1 (en)
GB (1) GB1432784A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4263313A (en) 1977-02-24 1981-04-21 Kali-Chemie Pharma Gmbh Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US5156842A (en) * 1987-06-19 1992-10-20 Elan Corporation, Plc Liquid suspension for oral administration
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
AT358530B (en) * 1978-04-25 1980-09-10 Plc Pharma Licences STABILIZATION PROCEDURE
FR2427100A1 (en) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Highly soluble and stable basic pharmaceuticals in glyceride mixt. - are prepd. by converting to fatty acid salts by addn. of free fatty acid
FR2500302B1 (en) * 1981-02-25 1985-11-15 Negma Laboratoires NEW PHARMACEUTICAL COMPOSITIONS OF INDOMETACIN
JPS5877810A (en) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk Oral drug composition containing polyglycerol unsaturated fatty acid ester
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS60153758A (en) * 1984-01-23 1985-08-13 Kao Corp Fat or oil composition
FR2569561B1 (en) * 1984-08-30 1990-05-18 Oreal STABLE ANTHRALIN COMPOSITION IN SATURATED FATTY ACID TRIGLYCERIDES OF PLANT ORIGIN WITH 6 TO 12 CARBON ATOMS
JP2537658B2 (en) * 1987-04-13 1996-09-25 小野薬品工業株式会社 Novel formulation containing ester or amide as active ingredient
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP5666760B2 (en) * 2005-03-31 2015-02-12 サントリーホールディングス株式会社 Composition containing lignan compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (en) *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4263313A (en) 1977-02-24 1981-04-21 Kali-Chemie Pharma Gmbh Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US5156842A (en) * 1987-06-19 1992-10-20 Elan Corporation, Plc Liquid suspension for oral administration
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds

Also Published As

Publication number Publication date
DE2357389A1 (en) 1974-05-22
CA1036072A (en) 1978-08-08
AU6254373A (en) 1975-05-15
BE807312A (en) 1974-03-01
FR2206943B1 (en) 1977-09-02
JPS4971127A (en) 1974-07-10
FR2206943A1 (en) 1974-06-14

Similar Documents

Publication Publication Date Title
GB1432784A (en) Orally administrable pharmaceutical compositions
CA2132012A1 (en) Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
DK128283A (en) PHARMACEUTICAL PREPARATIONS TO BE ADMINISTRATED ORAL
ES2097155T3 (en) EFFERVESCENT DOSAGE FORM AND METHOD OF ADMINISTRATION.
RU94032150A (en) Medicinal agent exhibiting delayed release of active-acting substance
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR880010758A (en) Sustained release preparations
BE900605A (en) PHARMACEUTICAL COMPOSITIONS WITH ANTI-INFLAMMATORY AND / OR ANALGESIC ACTIVITY, NON ULCEROGENIC.
DE3573884D1 (en) Substained release tablets and method for preparation thereof
MC1969A1 (en) METHODS FOR PREPARING ANTI-TUMOR COMPOUNDS, PHARMACEUTICAL FORMULATION CONTAINING THE SAME, USE THEREOF IN MEDICINE AND PHARMACY, AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARATION
DK0421541T3 (en) Shared tablet structure
WO2000025756A3 (en) Medicament for topical treatment of inflammatory intestinal diseases
ES531346A0 (en) PROCEDURE TO PRODUCE AN ORAL ADMINISTRATION TABLET OF CONTROLLED LIBERATION, INDEPENDENT OF THE PH
EP0271151A3 (en) Azumolene dosage form
IE35419B1 (en) Muscle-relaxant compositions
IE33949B1 (en) Compositions for treating gastrointestinal disorders
AU474505B2 (en) Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment
IE35711L (en) Pharmaceutical compositions
Ota et al. A double-blind comparison of haloperidol oral concentrate, haloperidol solutabs and placebo in the treatment of chronic schizophrenia.
MY129255A (en) A new physical form of artemisinin and its use in the production of pharmaceuticals
RU2173999C2 (en) Nonnarcotic analgetic and antipyretic drug and method of its preparing
Levy Pharmacy: Hospital Pharmacists' New Frontiers
KR790000319B1 (en) Process of manufacturing 2,4-diamino-pyrimidine with a sulphonamide
GB1454390A (en) Nasal decongestants
NL154419B (en) PROCESS FOR THE PREPARATION OF MEDICINAL PRODUCTS CONTAINING (BETA-PHENYLSULFINYLETHYL) -N, N'-DIPHENYL-MALONIC ACID MONOHYDRAZIDE AND / OR ONE OR MORE PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF.

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee